Pacific Capital Wealth Advisors, Inc Altimmune, Inc. Transaction History
Pacific Capital Wealth Advisors, Inc
- $592 Million
- Q3 2024
A detailed history of Pacific Capital Wealth Advisors, Inc transactions in Altimmune, Inc. stock. As of the latest transaction made, Pacific Capital Wealth Advisors, Inc holds 1,388 shares of ALT stock, worth $9,438. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,388Holding current value
$9,438% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALT
# of Institutions
190Shares Held
42.3MCall Options Held
1.05MPut Options Held
582K-
Black Rock Inc. New York, NY5.32MShares$36.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$33.4 Million0.0% of portfolio
-
State Street Corp Boston, MA3.91MShares$26.6 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.22MShares$21.9 Million0.01% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$18.7 Million2.23% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $333M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...